Aug 6, 2026 04:01PM
Jun 4, 2026 06:44AM
May 7, 2026 04:30PM
Mar 16, 2026 06:53AM
Mar 12, 2026 04:01PM
Jan 12, 2026 08:00AM
Dec 19, 2025 08:00AM IN8bio prices $40.2 million private placement for cancer therapy
Dec 19, 2025 08:00AM
Nov 6, 2025 04:00PM
Oct 27, 2025 08:00AM
Oct 13, 2025 06:42AM
Jun 2, 2025 07:30AM
Jun 2, 2025 07:30AM
Mar 13, 2025 04:05PM IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
Feb 14, 2025 09:00AM
Feb 14, 2025 09:00AM
Nov 12, 2024 04:26PM
Sep 4, 2024 04:02PM
Sep 4, 2024 04:01PM
Aug 12, 2024 08:06AM
Aug 12, 2024 08:05AM IN8bio Solidifies Position as a Clinical Leader of Gamma-Delta T Cell Therapy in Oncology with 100% of Treated AML Patients in Complete Remission and Receives FDA Guidance for Registrational Trial of
Jun 13, 2024 04:01PM
Jun 13, 2024 04:01PM
Apr 30, 2024 06:05AM
Nov 10, 2023 07:00AM
Oct 12, 2023 08:00AM
Sep 19, 2023 08:03AM
Aug 10, 2023 04:15PM IN8bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
May 12, 2023 08:00AM
Apr 25, 2023 08:02AM
Apr 25, 2023 08:00AM
Mar 30, 2023 04:15PM
Jan 5, 2023 07:03AM
Jan 5, 2023 07:00AM
Dec 8, 2022 07:07AM IN8bio, Inc (INAB) Announces FDA Clearance to Initiate a Phase 2 Clinical Trial of INB-400 Gamma-Delta T Cells for Glioblastoma
Dec 8, 2022 07:00AM
Nov 10, 2022 07:30AM
Aug 12, 2022 04:17PM
Aug 12, 2022 04:15PM
Jul 12, 2022 08:00AM
Apr 13, 2022 08:30AM
Mar 28, 2022 08:04AM IN8bio, Inc (INAB) Provides Clinical Update from the Ongoing Phase 1 Trial of INB-100
Mar 28, 2022 08:00AM
Jan 6, 2022 07:00AM
Jan 6, 2022 07:00AM
Dec 16, 2021 07:04AM
Dec 16, 2021 07:00AM
Nov 16, 2021 07:02AM
Nov 16, 2021 07:00AM IN8bio Appoints Trishna Goswami, M.D. as Chief Medical Officer
Oct 27, 2021 07:04AM

327,799 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All